טוען...
Exploring anti-malarial potential of FDA approved drugs: an in silico approach
BACKGROUND: The critically important issue on emergence of drug-resistant malarial parasites is compounded by cross resistance, where resistance to one drug confers resistance to other chemically similar drugs or those that share mode of action. This aspect requires discovery of new anti-malarial co...
שמור ב:
| הוצא לאור ב: | Malar J |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5516367/ https://ncbi.nlm.nih.gov/pubmed/28720135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-017-1937-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|